Center-Authored Papers

Filters: Author is Hawkins, Douglas S  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
X
Xu L, Wilson RA, Laetsch TW, Oliver D, Spunt SL, Hawkins DS, Skapek SX.  2016.  Potential pitfalls of mass spectrometry to uncover mutations in childhood soft tissue sarcoma: A report from the Children's Oncology Group.. Scientific reports. 6:33429. Abstract
W
Wolden SL, Lyden ER, Arndt CA, Hawkins DS, Anderson JR, Rodeberg DA, Morris CD, Donaldson SS.  2015.  Local Control for Intermediate-Risk Rhabdomyosarcoma: Results From D9803 According to Histology, Group, Site, and Size: A Report From the Children's Oncology Group.. International journal of radiation oncology, biology, physics. 93(5):1071-6. Abstract
Weiss AR, Lyden ER, Anderson JR, Hawkins DS, Spunt SL, Walterhouse DO, Wolden SL, Parham DM, Rodeberg DA, Kao SC et al..  2013.  Histologic and clinical characteristics can guide staging evaluations for children and adolescents with rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma Committee.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31(26):3226-32. Abstract
Walterhouse DO, Pappo AS, Meza JL, Breneman JC, Hayes-Jordan A, Parham DM, Cripe TP, Anderson JR, Meyer WH, Hawkins DS.  2017.  Reduction of cyclophosphamide dose for patients with subset 2 low-risk rhabdomyosarcoma is associated with an increased risk of recurrence: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.. Cancer. Abstract
V
Vo KT, Edwards JV, Epling LC, Sinclair E, Hawkins DS, Grier HE, Janeway KA, Barnette P, McIlvaine E, Krailo MD et al..  2016.  Impact of Two Measures of Micrometastatic Disease on Clinical Outcomes in Patients with Newly Diagnosed Ewing Sarcoma: A Report from the Children's Oncology Group.. Clinical cancer research : an official journal of the American Association for Cancer Research. 22(14):3643-50. Abstract
S
Spalding AC, Hawkins DS, Donaldson SS, Anderson JR, Lyden E, Laurie F, Wolden SL, Arndt CAS, Michalski JM.  2013.  The effect of radiation timing on patients with high-risk features of parameningeal rhabdomyosarcoma: an analysis of IRS-IV and D9803.. International journal of radiation oncology, biology, physics. 87(3):512-6. Abstract
Skapek SX, Anderson J, Barr FG, Bridge JA, Gastier-Foster JM, Parham DM, Rudzinski ER, Triche T, Hawkins DS.  2013.  PAX-FOXO1 fusion status drives unfavorable outcome for children with rhabdomyosarcoma: a children's oncology group report.. Pediatric blood & cancer. 60(9):1411-7. Abstract
Skapek SX, Anderson JR, Hill AD, Henry D, Spunt SL, Meyer W, Kao S, Hoffer FA, Grier HE, Hawkins DS et al..  2013.  Safety and efficacy of high-dose tamoxifen and sulindac for desmoid tumor in children: results of a Children's Oncology Group (COG) phase II study.. Pediatric blood & cancer. 60(7):1108-12. Abstract
Shern JF, Chen L, Chmielecki J, Wei JS, Patidar R, Rosenberg M, Ambrogio L, Auclair D, Wang J, Song YK et al..  2014.  Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors.. Cancer discovery. 4(2):216-31. Abstract
Sankaran H, Danysh HE, Scheurer ME, Okcu FM, Skapek SX, Hawkins DS, Spector LG, Erhardt EB, Grufferman S, Lupo PJ.  2016.  The Role of Childhood Infections and Immunizations on Childhood Rhabdomyosarcoma: A Report From the Children's Oncology Group.. Pediatric blood & cancer. Abstract
R
Russell H, Swint MJ, Lal L, Meza J, Walterhouse D, Hawkins DS, Okcu FM.  2014.  Cost minimization analysis of two treatment regimens for low-risk rhabdomyosarcoma in children: a report from the Children's Oncology Group.. Pediatric blood & cancer. 61(6):970-6. Abstract
Rudzinski ER, Teot LA, Anderson JR, Moore J, Bridge JA, Barr FG, Gastier-Foster JM, Skapek SX, Hawkins DS, Parham DM.  2013.  Dense pattern of embryonal rhabdomyosarcoma, a lesion easily confused with alveolar rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.. American journal of clinical pathology. 140(1):82-90. Abstract
Rudzinski ER, Anderson JR, Lyden ER, Bridge JA, Barr FG, Gastier-Foster JM, Bachmeyer K, Skapek SX, Hawkins DS, Teot LA et al..  2014.  Myogenin, AP2β, NOS-1, and HMGA2 are surrogate markers of fusion status in rhabdomyosarcoma: a report from the soft tissue sarcoma committee of the children's oncology group.. The American journal of surgical pathology. 38(5):654-9. Abstract
Rosenberg AR, Anderson JR, Lyden E, Rodeberg DA, Wolden SL, Kao SC, Parham DM, Arndt C, Hawkins DS.  2014.  Early response as assessed by anatomic imaging does not predict failure-free survival among patients with Group III rhabdomyosarcoma: a report from the Children's Oncology Group.. European journal of cancer (Oxford, England : 1990). 50(4):816-23. Abstract
Rodeberg DA, Wharam MD, Lyden ER, Stoner JA, Brown K, Wolden SL, Paidas CN, Donaldson SS, Hawkins DS, Spunt SL et al..  2015.  Delayed primary excision with subsequent modification of radiotherapy dose for intermediate-risk rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee.. International journal of cancer. Journal international du cancer. 137(1):204-11. Abstract
Richards MK, Dahl JP, Gow K, Goldin AB, Doski J, Goldfarb M, Nuchtern J, Langer M, Beierle EA, Vasudevan S et al..  2016.  Factors Associated With Mortality in Pediatric vs Adult Nasopharyngeal Carcinoma.. JAMA otolaryngology-- head & neck surgery. :1-7. Abstract
Raccor BS, Claessens AJ, Dinh JC, Park JR, Hawkins DS, Thomas SS, Makar KW, McCune JS, Totah RA.  2012.  Potential contribution of cytochrome P450 2B6 to hepatic 4-hydroxycyclophosphamide formation: in vitro and in vivo investigations.. Drug metabolism and disposition: the biological fate of chemicals. 40(1):54-63. Abstract
P
Pinto N, Park JR, Murphy E, Yearley J, McClanahan T, Annamalai L, Hawkins DS, Rudzinski ER.  2017.  Patterns of PD-1, PD-L1, and PD-L2 expression in pediatric solid tumors.. Pediatric blood & cancer. Abstract
O
Oberlin O, Rey A, Brown KLB, Bisogno G, Koscielniak E, Stevens MCG, Hawkins DS, Meyer WH, La TH, Carli M et al..  2015.  Prognostic Factors for Outcome in Localized Extremity Rhabdomyosarcoma. Pooled Analysis from Four International Cooperative Groups.. Pediatric blood & cancer. 62(12):2125-31. Abstract
N
Newman EN, Jones RL, Hawkins DS.  2012.  An evaluation of [F-18]-fluorodeoxy-D-glucose positron emission tomography, bone scan, and bone marrow aspiration/biopsy as staging investigations in Ewing Sarcoma.. Pediatric blood & cancer. Abstract
M
Marina NM, Smeland S, Bielack SS, Bernstein M, Jovic G, Krailo MD, Hook JM, Arndt C, van den Berg H, Brennan B et al..  2016.  Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial.. The Lancet. Oncology. 17(10):1396-1408. Abstract
MacQuarrie KL, Yao Z, Fong AP, Diede SJ, Rudzinski ER, Hawkins DS, Tapscott SJ.  2013.  Comparison of Genome-Wide Binding of MyoD in Normal Human Myogenic Cells and Rhabdomyosarcomas Identifies Regional and Local Suppression of Promyogenic Transcription Factors.. Molecular and cellular biology. 33(4):773-84. Abstract
L
Lupo PJ, Danysh HE, Plon SE, Curtin K, Malkin D, Hettmer S, Hawkins DS, Skapek SX, Spector LG, Papworth K et al..  2015.  Family history of cancer and childhood rhabdomyosarcoma: a report from the Children's Oncology Group and the Utah Population Database.. Cancer medicine. 4(5):781-90. Abstract
Lupo PJ, Danysh HE, Skapek SX, Hawkins DS, Spector LG, Zhou R, Okcu FM, Papworth K, Erhardt EB, Grufferman S.  2014.  Maternal and birth characteristics and childhood rhabdomyosarcoma: a report from the Children's Oncology Group.. Cancer causes & control : CCC. 25(7):905-13. Abstract
Lupo PJ, Zhou R, Skapek SX, Hawkins DS, Spector LG, Scheurer ME, Fatih Okcu M, Melin B, Papworth K, Erhardt EB et al..  2014.  Allergies, atopy, immune-related factors and childhood rhabdomyosarcoma: A report from the children's oncology group.. International journal of cancer. Journal international du cancer. 134(2):431-6. Abstract